🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
This phase I trial studies the best dose and side effects of TAK-659 and pa...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2019-03-05
Trial ID
NCT03756818
Treatments Being Tested
The purpose of this study is to characterize the effect of food on the sing...
Status
Withdrawn
Location
Yale Cancer Center
Start Date
2018-02-28
Trial ID
NCT03359733
Treatments Being Tested
The purpose of the Phase 1b dose finding phase is to determine the safety, ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2015-03-09
Trial ID
NCT02323113
Treatments Being Tested
The purpose of this study is to evaluate the maximum tolerated dose (MTD) o...
Status
Terminated
Location
UCSD
Start Date
2016-08-12
Trial ID
NCT02834247
The purpose of this study is to assess the efficacy of TAK-659 measured by ...
Status
Terminated
Location
University of Kansas Medical Center
Start Date
2017-10-10
Trial ID
NCT03123393
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, maximum...
Status
Terminated
Location
NHO Nagoya Medical Center
Start Date
2017-08-01
Trial ID
NCT03238651
Treatments Being Tested
This study is an open-label, multicenter, phase 1, dose escalation study of...
Status
Completed
Location
Florida Cancer Specialists, Sarasota FL
Start Date
2013-12-31
Trial ID
NCT02000934
Treatments Being Tested
The purpose of this research study is to evaluate a new investigational dru...
Status
Completed
Location
Northwestern University
Start Date
2019-03-13
Trial ID
NCT03742258
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Withdrawn
Location
University of Alabama at Birmingham
Start Date
2019-04-03
Trial ID
NCT03772288